Cardiovascular implantable device infections

被引:14
作者
Viola G.M. [1 ]
Darouiche R.O. [2 ]
机构
[1] Department of Medicine, Division of Infectious Diseases, University of Texas MD Anderson Cancer Center, Houston, TX 77030
[2] Department of Medicine, Division of Infectious Disease, Michael E. DeBakey VA Medical Center, Houston, TX 77030
关键词
Bacteremia; Bioprosthetic valve; Bioprosthetic valves; Cardiac device; Cardiovascular implantable electronic devices; CIED; Coronary artery stents; Defibrillator; Endocarditis; Enterococci; Gram-negative bacteria; Gram-positive bacteria; Infection; Mechanical valve; Mechanical valves; Pacemaker; Percutaneous coronary interventions; Permanent pacemaker; PPM; Prosthetic valve endocarditis; PVE; Staphylococcus; Stent; Streptococcus; TAH; TEE; Total artificial heart; Transesophageal echocardiogram; Transthoracic echocardiogram; TTE; VAD; Valve; Ventricular assist device;
D O I
10.1007/s11908-011-0187-7
中图分类号
学科分类号
摘要
As life expectancy continues to increase and biotechnology advances, the use of cardiovascular implantable devices will continue to rise. Unfortunately, despite modern medical advances, the infection and mortality rates remain excessively elevated. This article reviews the pathophysiology and general concepts of cardiac device-related infections, including the physical and chemical characteristics of the medical device, host response to the medical device, and the microbiologic virulence factors. Infections of the most commonly utilized cardiovascular implantable devices, including cardiovascular implantable electronic devices, bioprosthetic and mechanical valves, ventricular assist devices, total artificial hearts, and coronary artery stents, are reviewed in detail. © 2011 Springer Science+Business Media, LLC.
引用
收藏
页码:333 / 342
页数:9
相关论文
共 90 条
[1]  
Cabell C.H., Heidenreich P.A., Chu V.H., Moore C.M., Stryjewski M.E., Corey G.R., Fowler Jr. V.G., Increasing rates of cardiac device infections among Medicare beneficiaries: 1990-1999, American Heart Journal, 147, 4, pp. 582-586, (2004)
[2]  
Monkowski D.H., Axelrod P., Fekete T., Hollander T., Furukawa S., Samuel R., Infections associated with ventricular assist devices: Epidemiology and effect on prognosis after transplantation, Transplant Infectious Disease, 9, 2, pp. 114-120, (2007)
[3]  
Darouiche R.O., Treatment of infections associated with surgical implants, New England Journal of Medicine, 350, 14, pp. 1422-1429, (2004)
[4]  
Darouiche R.O., Device-associated infections: A macroproblem that starts with microadherence, Clinical Infectious Diseases, 33, 9, pp. 1567-1572, (2001)
[5]  
Phaller M.A., Herwaldt L.A., Laboratory, clinical, and epidemiological aspects of coagulase-negative staphylococci, Clin Microbiol Rev, 1, pp. 281-299, (1988)
[6]  
Baddour L.M., Epstein A.E., Erickson C.C., Et al., Update on cardiovascular implantable electronic device infections and their management: A scientific statement from the American Heart Association, Circulation, 121, pp. 458-477, (2010)
[7]  
Baddour L.M., Bettmann M.A., Bolger A.F., Epstein A.E., Ferrieri P., Gerber M.A., Gewitz M.H., Jacobs A.K., Levison M.E., Newburger J.W., Pallasch T.J., Wilson W.R., Baltimore R.S., Falace D.A., Shulman S.T., Tani L.Y., Taubert K.A., Nonvalvular cardiovascular device-related infections, Circulation, 108, 16, pp. 2015-2031, (2003)
[8]  
Rao P.S., Palacios I.F., Bach R.G., Bitar S.R., Sideris E.B., Healing response to the clamshell device for closure of intracardiac defects in humans, Catheterization and Cardiovascular Interventions, 54, 1, pp. 101-111, (2001)
[9]  
Lin K., Hsu P.-P., Chen B.P., Yuan S., Usami S., Shyy J.Y.-J., Li Y.-S., Chien S., Molecular mechanism of endothelial growth arrest by laminar shear stress, Proceedings of the National Academy of Sciences of the United States of America, 97, 17, pp. 9385-9389, (2000)
[10]  
Fisher A.B., Chien S., Barakat A.I., Et al., Endothelial cellular response to altered shear stress, Am J Physiol Lung Cell Mol Physiol, 281, (2001)